An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.
- 1 August 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 86 (2) , 683-687
- https://doi.org/10.1161/01.cir.86.2.683
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activatorThe American Journal of Cardiology, 1991
- Patency of the infarct-related coronary artery and ventricular geometryThe American Journal of Cardiology, 1991
- Principles and practice of coronary thrombolysis and conjunctive treatmentThe American Journal of Cardiology, 1991
- Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversiesJournal of the American College of Cardiology, 1990
- A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: A pilot studyJournal of the American College of Cardiology, 1989
- Improved survival up to four years after early coronary thrombolysisThe American Journal of Cardiology, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980